HighTower Advisors’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-27,262
Closed -$76K 3891
2023
Q4
$76K Buy
27,262
+500
+2% +$1.44K ﹤0.01% 3247
2023
Q3
$88K Hold
26,762
﹤0.01% 3125
2023
Q2
$67K Hold
26,762
﹤0.01% 3138
2023
Q1
$30K Hold
26,762
﹤0.01% 3105
2022
Q4
$22K Hold
26,762
﹤0.01% 3122
2022
Q3
$39K Hold
26,762
﹤0.01% 2916
2022
Q2
$53K Hold
26,762
﹤0.01% 2901
2022
Q1
$86K Buy
26,762
+195
+0.7% +$541 ﹤0.01% 3015
2021
Q4
$81K Buy
26,567
+10,000
+60% +$37.5K ﹤0.01% 2960
2021
Q3
$68K Buy
+16,567
New +$70.3K ﹤0.01% 2902
2015
Q3
Hold
0
-$6K 1916
2015
Q2
Hold
0
1505
2015
Q1
Hold
0
1599
2014
Q4
Hold
0
1566
2014
Q3
Hold
0
1438
2014
Q2
Hold
0
1483
2014
Q1
Hold
0
1377
2013
Q4
Hold
0
1413
2013
Q3
Hold
0
1200
2013
Q2
Hold
0
1168

Other funds holding NSPR

HighTower Advisors's NSPR Position: Q1 2024 in Review

HighTower Advisors sold out of InspireMD (NSPR) in Q1 2024, closing a stake of 27,262 shares — an estimated $76K sold.

HighTower Advisors first reported a position in NSPR in Q3 2021 and held it in 10 quarters. The position peaked at $88K in Q3 2023. 28 funds tracked by Wall St. Rank hold NSPR as of Q1 2024.

  • HighTower Advisors reported no remaining InspireMD position as of Q1 2024 after selling out during the quarter.
  • HighTower Advisors sold 27,262 InspireMD shares in Q1 2024, an estimated $76K.
  • HighTower Advisors first reported a position in InspireMD in Q3 2021 and held it in 10 quarters.
  • HighTower Advisors's InspireMD position peaked at $88K in Q3 2023.
  • 28 funds tracked by Wall St. Rank held InspireMD as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.